市場調査レポート

商品コード

自己免疫疾患診断市場：製品タイプ別（試薬、キット、アッセイ、機器）、検査タイプ別（ANA、CRP、ESR、リウマチ因子、ルーチン検査）、疾患タイプ別（全身性、局所性）、エンドユーザー別（病院、診断ラボ、研究機関）-2030年までの世界予測

Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor, Routine Test), Disease Type (Systemic, Localized), End User (Hospital, Diagnostic Lab, Research)-Global Forecast to 2030

出版日: 2023年08月18日
発行: Meticulous Research
ページ情報: 英文 261 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,175 613,558円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,875 863,390円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global Site License)

USD 7,875 1,157,310円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.96円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

自己免疫疾患診断市場は、2023年から2030年までのCAGRが7.2%で、2030年までに98億4,000万米ドルに達すると予測されます。

本レポートでは、広範な1次調査と2次調査、市場シナリオの詳細な分析により、主要な市場促進要因、抑制要因、課題、機会を調査しています。自己免疫疾患診断市場の成長は、自己免疫疾患の有病率の増加、早期診断の重視の高まり、自己免疫疾患に関する意識の高まりに起因しています。しかし、自己免疫疾患の診断が難しいことが市場の成長を抑制しています。新興国と自己免疫疾患領域への投資・資金調達の増加は、同市場のプレーヤーに成長機会をもたらすと期待されています。さらに、不利な償還シナリオと診断遅延や誤診率の高さは、市場成長にとって大きな課題です。

概要
市場成長に影響を与える要因
- 市場力学
  - 診断検査の成長を促進する自己免疫疾患の有病率の増加
  - 自己免疫疾患に関する意識の高まりが診断製品の採用を後押し
  - 市場成長機会を生み出す自己免疫疾患領域への投資と資金調達の増加
- 要因分析
ポーターのファイブフォース分析
規制分析
- 北米
  - 米国
  - カナダ
- 欧州
- アジア太平洋
  - 中国
  - インド
  - 日本
- ラテンアメリカ
- 中東・アフリカ

第5章自己免疫疾患診断市場の評価-製品タイプ別

概要
試薬、キット、アッセイ
機器
ソフトウェアとサービス

第6章自己免疫疾患診断市場の評価-検査タイプ別

概要
抗核抗体（ANA）検査
C反応性タンパク質検査
赤血球沈降速度検査
リウマトイド因子検査
免疫グロブリン検査
定期血液検査
その他の自己免疫検査

第7章自己免疫疾患診断の世界市場：疾患タイプ別

概要
全身性自己免疫疾患
- 関節リウマチ
- 乾癬
- 全身性エリテマトーデス
- 多発性硬化症
- その他の全身性自己免疫疾患
臓器特異的自己免疫疾患
- 1型糖尿病
- セリアック病
- 炎症性腸疾患
- その他の臓器特異的自己免疫疾患

第8章自己免疫疾患診断市場：エンドユーザー別評価

概要
診断研究所
病院・クリニック
学術・研究機関

第9章自己免疫疾患診断市場の地域別評価

概要
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- イタリア
- スペイン
- フランス
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- その他アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第10章競合分析

概要
主要成長戦略
競合ベンチマーキング
競合ダッシュボード
- 業界リーダー
- 市場差別化要因
- 先行企業
- 新興企業

第11章企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略的展開）

Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG（A Subsidiary of Siemens AG）
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Beckman Coulter, Inc.（Subsidiary of Danaher Corporation）
Becton, Dickinson and Company
PerkinElmer, Inc.
Grifols, S.A.
Creative Diagnostics

（注：上位5社のSWOT分析を提供します。）

第12章付録

図表

Table 1 Global Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 2 Global Autoimmune Disease Diagnostics Market for Reagents, Kits, And Assays, By Country/Region, 2021-2030 (USD Million)
Table 3 Global Autoimmune Disease Diagnostics Market for Instruments, By Country/Region, 2021-2030 (USD Million)
Table 4 Global Autoimmune Disease Diagnostics Market for Software & Services, By Country/Region, 2021-2030 (USD Million)
Table 5 Global Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 6 Global Antinuclear Antibodies (ANA) Test Market, By Country/Region, 2021-2030 (USD Million)
Table 7 Global C-Reactive Protein Test Market, By Country/Region, 2021-2030 (USD Million)
Table 8 Global Erythrocyte Sedimentation Rate Test Market, By Country/Region, 2021-2030 (USD Million)
Table 9 Global Rheumatoid Factor Test Market, By Country/Region, 2021-2030 (USD Million)
Table 10 Global Immunoglobulin Test Market, By Country/Region, 2021-2030 (USD Million)
Table 11 Global Routine Blood Test Market, By Country/Region, 2021-2030 (USD Million)
Table 12 Global Other Autoimmune Test Market, By Country/Region, 2021-2030 (USD Million)
Table 13 Global Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 14 Global Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 15 Global Systemic Autoimmune Disease Diagnostics Market by Country/Region, 2021-2030 (USD Million)
Table 16 Global Rheumatoid Arthritis Diagnostics Market by Country/Region, 2021-2030 (USD Million)
Table 17 Global Psoriasis Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 18 Global Systemic Lupus Erythematosus Diagnostics Market by Country/Region, 2021-2030 (USD Million)
Table 19 Global Multiple Sclerosis Diagnostics Market by Country/Region, 2021-2030 (USD Million)
Table 20 Global Other Systemic Autoimmune Diseases Diagnostics Market by Country/Region, 2021-2030 (USD Million)
Table 21 Global Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 22 Global Organ-specific Autoimmune Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 23 Global Type-1 Diabetes Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 24 Global Celiac Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 25 Research Studies for Crohn's Disease and Ulcerative Colitis in Canada
Table 26 Global Inflammatory Bowel Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 27 Global Other Organ-specific Autoimmune Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 28 Global Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 29 Global Autoimmune Disease Diagnostics Market for Diagnostic Laboratories, By Country/Region, 2021-2030 (USD Million)
Table 30 Global Autoimmune Disease Diagnostics Market for Hospitals & Clinics, By Country/Region, 2021-2030 (USD Million)
Table 31 Global Autoimmune Disease Diagnostics Market for Academic & Research Institutes, By Country/Region, 2021-2030 (USD Million)
Table 32 Global Autoimmune Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 33 North America: Autoimmune Disease Diagnostics Market, By Country, 2021-2030 (USD Million)
Table 34 North America.: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 35 North America.: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 36 North America.: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 37 North America: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 38 North America: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 39 North America: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 40 U.S.: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 41 U.S.: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 42 U.S.: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 43 U.S.: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 44 U.S.: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 45 U.S.: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 46 Canada: Arthritis Prevalence, 2018-2021
Table 47 Canada: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 48 Canada: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 49 Canada: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 50 Canada: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 51 Canada: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 52 Canada: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 53 Europe: Autoimmune Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 54 Europe: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 55 Europe: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 56 Europe: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 57 Europe: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 58 Europe: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 59 Europe: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 60 Germany: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 61 Germany: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 62 Germany: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 63 Germany: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 64 Germany: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 65 Germany: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 66 U.K.: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 67 U.K.: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 68 U.K.: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 69 U.K.: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 70 U.K.: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 71 U.K.: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 72 Italy: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 73 Italy: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 74 Italy: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 75 Italy: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 76 Italy: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 77 Italy: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 78 Spain: Number of People with Type 1 Diabetes (2022)
Table 79 Spain: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 80 Spain: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 81 Spain: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 82 Spain: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 83 Spain: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 84 Spain: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 85 France: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 86 France: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 87 France: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 88 France: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 89 France: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 90 France: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 91 Rest of Europe: Number of People with Type 1 Diabetes, 2022
Table 92 RoE: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 93 RoE: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 94 RoE: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 95 RoE: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 96 RoE: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 97 RoE: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 98 Asia-Pacific: Autoimmune Disease Diagnostics Market, By Country/Region, 2021-2030 (USD Million)
Table 99 Asia-Pacific: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 100 Asia-Pacific: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 101 Asia-Pacific: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 102 Asia-Pacific: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 103 Asia-Pacific: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 104 Asia-Pacific: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 105 China: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 106 China: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 107 China: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 108 China: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 109 China: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 110 China: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 111 Comparison of Type 1 Diabetes in Asia-Pacific Countries (2022)
Table 112 India: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 113 India: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 114 India: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 115 India: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 116 India: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 117 India: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 118 Japan: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 119 Japan: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 120 Japan: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 121 Japan: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 122 Japan: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 123 Japan: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 124 RoAPAC: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 125 RoAPAC: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 126 RoAPAC: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 127 RoAPAC: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 128 RoAPAC: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 129 RoAPAC: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 130 Latin America: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 131 Latin America: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 132 Latin America: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 133 Latin America: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 134 Latin America: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 135 Latin America: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 136 Middle East & Africa: Autoimmune Disease Diagnostics Market, By Product Type, 2021-2030 (USD Million)
Table 137 Middle East & Africa: Autoimmune Disease Diagnostics Market, By Test Type, 2021-2030 (USD Million)
Table 138 Middle East & Africa: Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 139 Middle East & Africa: Systemic Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 140 Middle East & Africa: Organ-specific Autoimmune Disease Diagnostics Market, By Disease Type, 2021-2030 (USD Million)
Table 141 Middle East & Africa: Autoimmune Disease Diagnostics Market, By End User, 2021-2030 (USD Million)
Table 142 Recent Developments, By Company, 2020-2023

Product Code: MRHC - 104721

The autoimmune disease diagnostics market is expected to reach $9.84 billion by 2030, at a CAGR of 7.2% from 2023 to 2030.

With extensive primary and secondary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of the autoimmune disease diagnostics market is attributed to the increasing prevalence of autoimmune disorders, the growing emphasis on early diagnosis, and the rising awareness regarding autoimmune diseases. However, difficulties in diagnosing autoimmune diseases restrain the growth of this market. Emerging economies and increasing investments & funding in the autoimmune diseases space are expected to generate growth opportunities for the players in this market. Moreover, the unfavorable reimbursement scenario and high rate of delayed diagnosis or misdiagnosis are major challenges for market growth.

Based on product type, the autoimmune disease diagnostics market is segmented into reagents, assays & kits, and instruments. The reagents, assays & kits segment is expected to grow at the fastest CAGR during the forecast period. The growing prevalence of autoimmune diseases, recurrent use of reagents, assays & kits, and their increasing number of launches for autoimmune diseases by major market players are the major factors responsible for the segment growth.

The growing prevalence of autoimmune diseases has prompted major players operating in the autoimmune disease diagnostics market to focus on developing, approving, and launching kits & assays for monitoring and diagnosing autoimmune diseases, further driving their adoption. For instance, in 2022, Thermo Fisher Scientific Inc. (U.S.) launched EliA RNA Pol III and EliA Rib-P blood tests for the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE). This test further expands the company's product offerings for autoimmune disease diagnostics.

Based on test type, the autoimmune disease diagnostics market is segmented into antinuclear antibodies test (ANA), C-reactive protein test (CRP), erythrocyte sedimentation rate test, rheumatoid factor test, immunoglobulins test, routine blood tests, and other test types. In 2023, the antinuclear antibodies test (ANA) segment is expected to account for the largest share of the market. This segment's large market share is attributed to the increasing prevalence of autoimmune diseases and the widespread use of the ANA test for diagnosing autoimmune diseases due to its affordability, ease of administration, and heightened sensitivity & specificity.

According to the National Stem Cells Foundation, over 80 autoimmune diseases affect nearly 4% of the global population. The high burden of autoimmune diseases leads to the adoption of the antinuclear antibodies test, which is used as a primary test for several autoimmune diseases.

Based on disease type, the autoimmune disease diagnostics market is segmented into systemic autoimmune diseases and organ-specific autoimmune diseases. In 2023, the systemic autoimmune diseases segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the higher prevalence of systemic autoimmune diseases compared to organ-specific conditions, increasing initiatives to raise awareness about these diseases, and the continuous growth in research activities related to autoimmune conditions. The Arthritis Foundation (AF) estimates that the global prevalence of RA is 0.5 to 1% in developed countries. A 2020 review found that the prevalence of RA in the Middle East and Africa ranged from 0.06 to 3.4%. Rheumatoid arthritis requires long-term monitoring and management.

Based on end user, the autoimmune disease diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, and academic & research institutes. In 2023, the diagnostic laboratories segment is expected to account for the largest share of the market. Diagnostic laboratories receive samples from various healthcare centers, including hospitals and clinics. Diagnostics laboratories are crucial in providing accurate diagnostic results and managing disease management. Diagnostic laboratories process more samples in less time due to the well-equipped systems and the presence of skilled professionals. These factors contribute to the large market share of this segment in the autoimmune diseases diagnostics market.

An in-depth analysis of the geographical scenario of the autoimmune disease diagnostics market provides detailed qualitative and quantitative insights into five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, along with the coverage of major countries in each region. Asia-Pacific is slated to register the highest CAGR during the forecast period. The market growth in this region is attributed to the growing prevalence and incidence of celiac diseases & rheumatoid arthritis, unhealthy lifestyle, government initiatives supporting research in autoimmune diseases, and increasing expenditure on the research of autoimmune diseases.

Some of the key players operating in the global autoimmune disease diagnostics market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Grifols, S.A. (Spain), and Creative Diagnostics (U.S.).

Scope of the Report

Autoimmune Disease Diagnostics Market, by Product Type

Reagents, Assays, and Kits
Instruments
Software & Services

Autoimmune Disease Diagnostics Market, by Test Type

Antinuclear Antibodies (ANA) Test
Rheumatoid Factor Test
Immunoglobulins Test
Routine Blood Tests Test
C-reactive Protein (CRP) Test
Erythrocyte Sedimentation Rate (ESR) Test
Other Test Types

(Note - Other test types include (Anti-double stranded DNA, Extractable nuclear antigen, Anti-signal recognition particle tests, Ferritin, and Anti-cyclic Citrullinated Peptide (Anti-CCP) Antibodies)

Autoimmune Disease Diagnostics Market, by Disease Type

Systemic Autoimmune Diseases
- Rheumatoid Arthritis
- Psoriasis
- Systemic Lupus Erythematosus
- Multiple Sclerosis
- Other Systemic Autoimmune Diseases

(Other systemic autoimmune diseases include systemic scleroderma, dermatomyositis, Sjogren's syndrome, mixed connective tissue disease, Behcet syndrome, sarcoidosis, and myasthenia gravies, among others)

Organ-specific Autoimmune Diseases
- Type-1 Diabetes
- Celiac Diseases
- Inflammatory Bowel Disease
- Other Organ-Specific Diseases

(Other organ-specific autoimmune diseases include Addison's disease, Grave's disease, Guillain-Barre syndrome, Hashimoto's thyroiditis, and Sclerosing cholangitis, among others)

Autoimmune Disease Diagnostics Market, by End User

Hospitals & Clinics
Diagnostic Laboratories
Academic & Research Institutes

Autoimmune Disease Diagnostics Market, by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process Of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions For the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Factors Affecting Market Growth
- 4.2.1. Market Dynamics
  - 4.2.1.1. Increasing Prevalence of Autoimmune Disorders Driving Growth in Diagnostic Testing
  - 4.2.1.2. Rising Awareness Regarding Autoimmune Diseases Boosting the Adoption of Diagnostic Products
  - 4.2.1.3. Increasing Investments & Funding in The Autoimmune Diseases Space Generating Market Growth Opportunities
- 4.2.2. Factor Analysis
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Buyers
- 4.3.2. Bargaining Power of Suppliers
- 4.3.3. Threat of Substitutes
- 4.3.4. Threat of New Entrants
- 4.3.5. Degree of Competition
4.4. Regulatory Analysis
- 4.4.1. North America
  - 4.4.1.1. U.S.
  - 4.4.1.2. Canada
- 4.4.2. Europe
- 4.4.3. Asia-Pacific
  - 4.4.3.1. China
  - 4.4.3.2. India
  - 4.4.3.3. Japan
- 4.4.4. Latin America
- 4.4.5. Middle East & Africa

5. Autoimmune Disease Diagnostics Market Assessment- by Product Type

5.1. Overview
5.2. Reagents, Kits, & Assays
5.3. Instruments
5.4. Software & Services

6. Autoimmune Disease Diagnostics Market Assessment-by Test Type

6.1. Overview
6.2. Antinuclear Antibodies (ANA) Test
6.3. C-Reactive Protein Test
6.4. Erythrocyte Sedimentation Rate Test
6.5. Rheumatoid Factor Test
6.6. Immunoglobulins Test
6.7. Routine Blood Test
6.8. Other Autoimmune Tests

7. Global Autoimmune Disease Diagnostics Market-by Disease Type

7.1. Overview
7.2. Systemic Autoimmune Diseases
- 7.2.1. Rheumatoid Arthritis
- 7.2.2. Psoriasis
- 7.2.3. Systemic Lupus Erythematosus
- 7.2.4. Multiple Sclerosis
- 7.2.5. Other Systemic Autoimmune Diseases
7.3. Organ-specific Autoimmune Diseases
- 7.3.1. Type-1 Diabetes
- 7.3.2. Celiac Disease
- 7.3.3. Inflammatory Bowel Diseases
- 7.3.4. Other Organ-specific Autoimmune Diseases

8. Autoimmune Disease Diagnostics Market Assessment-by End User

8.1. Overview
8.2. Diagnostic Laboratories
8.3. Hospitals & Clinics
8.4. Academic & Research Institutes

9. Autoimmune Disease Diagnostics Market Assessment-by Geography

9.1. Overview
9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
9.3. Europe
- 9.3.1. Germany
- 9.3.2. U.K.
- 9.3.3. Italy
- 9.3.4. Spain
- 9.3.5. France
- 9.3.6. Rest of Europe
9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. India
- 9.4.3. Japan
- 9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa

10. Competition Analysis

10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

11.1 Abbott Laboratories
11.2. F. Hoffmann-La Roche Ltd.
11.3. Siemens Healthineers AG (A Subsidiary of Siemens AG)
11.4. Thermo Fisher Scientific, Inc.
11.5. Bio-Rad Laboratories, Inc.
11.6. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.7. Becton, Dickinson and Company
11.8. PerkinElmer, Inc.
11.9. Grifols, S.A.
11.10. Creative Diagnostics

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

12.1. Available Customization
12.2. Related Reports

Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor, Routine Test), Disease Type (Systemic, Localized), End User (Hospital, Diagnostic Lab, Research)-Global Forecast to 2030

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章市場洞察

第5章自己免疫疾患診断市場の評価-製品タイプ別

第6章自己免疫疾患診断市場の評価-検査タイプ別

第7章自己免疫疾患診断の世界市場：疾患タイプ別

第8章自己免疫疾患診断市場：エンドユーザー別評価

第9章自己免疫疾患診断市場の地域別評価

第10章競合分析

第11章企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略的展開）

第12章付録

Scope of the Report

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Autoimmune Disease Diagnostics Market Assessment- by Product Type

6. Autoimmune Disease Diagnostics Market Assessment-by Test Type

7. Global Autoimmune Disease Diagnostics Market-by Disease Type

8. Autoimmune Disease Diagnostics Market Assessment-by End User

9. Autoimmune Disease Diagnostics Market Assessment-by Geography

10. Competition Analysis

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

12. Appendix

Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor, Routine Test), Disease Type (Systemic, Localized), End User (Hospital, Diagnostic Lab, Research)-Global Forecast to 2030

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

第5章 自己免疫疾患診断市場の評価-製品タイプ別

第6章 自己免疫疾患診断市場の評価-検査タイプ別

第7章 自己免疫疾患診断の世界市場：疾患タイプ別

第8章 自己免疫疾患診断市場：エンドユーザー別評価

第9章 自己免疫疾患診断市場の地域別評価

第10章 競合分析

第11章 企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略的展開）

第12章 付録

Scope of the Report

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Autoimmune Disease Diagnostics Market Assessment- by Product Type

6. Autoimmune Disease Diagnostics Market Assessment-by Test Type

7. Global Autoimmune Disease Diagnostics Market-by Disease Type

8. Autoimmune Disease Diagnostics Market Assessment-by End User

9. Autoimmune Disease Diagnostics Market Assessment-by Geography

10. Competition Analysis

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

12. Appendix

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章市場洞察

第5章自己免疫疾患診断市場の評価-製品タイプ別

第6章自己免疫疾患診断市場の評価-検査タイプ別

第7章自己免疫疾患診断の世界市場：疾患タイプ別

第8章自己免疫疾患診断市場：エンドユーザー別評価

第9章自己免疫疾患診断市場の地域別評価

第10章競合分析

第11章企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略的展開）

第12章付録